Skip to content
Sign up to receive our free weekday morning edition, and you'll never miss a scoop.
Gene L. Dodaro, U.S. comptroller general

Bipartisan group requests data on ‘burden’ of swipe fees on federal budget

We’ve got another salvo to report in Washington’s credit card wars. This time, pro-retail lawmakers are trying to pull the finances of the federal government into the fight.

A bipartisan group of House members and senators will send a letter this afternoon to Comptroller General Gene Dodaro that asks for a full accounting of how much the federal government itself has been spending on credit card swipe fees in recent years.

Led by Rep. Lance Gooden (R-Texas) and Sen. Dick Durbin (D-Ill.), the members say they’re “concerned with the increasing burden of interchange fees paid by the federal government, an issue that affects countless taxpayers and nearly every federal agency.” The lawmakers estimate that “excessive fees” could cost the federal budget more than $200 million a year.

Several of the lawmakers signing on to this letter have been pushing for a vote on the Credit Card Competition Act. That bill is an attempt to undercut the market dominance of payment giants Mastercard and Visa by requiring the firms to offer another choice of payment processor on their cards. Banks have been fighting that legislative effort fiercely.

Here’s more from the letter, which you can read in full here.

Other signees will include Sens. Roger Marshall (R-Kan.) and Peter Welch (D-Vt.) and Reps. Zoe Lofgren (D-Calif.), Tom Tiffany (R-Wis.) and Jeff Van Drew (R-N.J.).

Presented by AstraZeneca

The 340B program was created to help patients. Instead, it’s helping hospitals earn massive profits. The 340B Rebate Model Pilot uses rapid verification of existing data to prevent duplicate discounts, strengthening program transparency and efficiency. Urge HHS to implement the Rebate Model Pilot and ensure 340B functions as intended. Get the facts.

Editorial photos provided by Getty Images. Political ads courtesy of AdImpact.

Presented by AstraZeneca

The 340B program is supposed to help vulnerable patients—but without strong safeguards, it’s siphoning away funds that could be used for free and charitable medicine. The 340B Rebate Model Pilot improves program integrity, preventing duplicate discounts and strengthening accountability. Urge HHS to implement the pilot today. Learn why it matters.

Welcome to Punchbowl News AM! We're glad to have you here.

Want to get more of what you need? Share a bit more about yourself to help us tailor your reader experience.

Thank you for signing up!

Thank you for signing up!

 

We have sent you a confirmation email. Please follow the provided instructions to complete your sign-up.

Thank you for confirming! You are now subscribed to the Punchbowl News AM list.

You're subscribed! Welcome to the community.